Diagnostics to support the scaling up of shorter, safer tuberculosis regimens
The 1/4/6x24 Campaign, launched in 2022, calls on stakeholders to implement the shortest and best available tuberculosis regimens—1 month or once-weekly for tuberculosis prevention, 4 months for drug-sensitive tuberculosis, and 6 months for drug-resistant tuberculosis—by the end of 2024.
Realising the promise of these shorter regimens requires urgently addressing gaps in tuberculosis screening and diagnosis, the weakest link in the cascade of care.
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00217-3/fulltext